Comparison of Brand versus Generic Antiepileptic Drug Adverse Event Reporting Rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

http://www.epires-journal.com/article/S0920-1211(17)30156-0/fulltext?rss=yes

Source: Epilepsy Research - June 13, 2017 Category: Neurology Authors: Md. Motiur Rahman, Yasser Alatawi, Ning Cheng, Jingjing Qian, Annya V. Plotkina, Peggy L. Peissig, Richard L. Berg, David Page, Richard A. Hansen Source Type: research

More News: Epilepsy | Food and Drug Administration (FDA) | Neurology